Norovirus bivalent vaccine (GI.1/GII.4) recombinant

· National Vaccine and Serum Institute, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Norovirus bivalent vaccine (GI.1/GII.4) recombinant, covering 2022-10-28 to 2022-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha) [Phase 2]

See pricing